Pharmacyclics (PCYC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (517)	9/10/1999 11:07:00 AM
From: Biomaven	Read Replies (1) of 717

wow.... let's dilute more companies It's conceivable (as I think I mentioned when the secondary was announced) that this is one of those rare companies where a secondary can actually help the stock. They have a very small float and a compelling, but mostly little known or misunderstood story. The stock has traditionally been illiquid with big spreads, and the increased attention and the increased float may well be positives. Alternatively, we may be looking at an incipient munch - I would be most upset if this were to happen any time soon. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next